Literature DB >> 12447751

Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans.

Patrícia L Falcão1, Rodrigo Correa-Oliveira, Lúcia A O Fraga, André Talvani, Amanda E I Proudfoot, Tim N C Wells, Timothy J Williams, Peter J Jose, Mauro M Teixeira.   

Abstract

Chemokines play an important role during granulomatous inflammation in murine models of Schistosoma mansoni infection. Here, the expression and possible roles of chemokines during human S. mansoni infection were examined. Compared with uninfected individuals, infected patients had elevated plasma concentrations of macrophage inflammatory protein (MIP)-1alpha, RANTES (regulated on activation, normally T cell-expressed and secreted), and eotaxin. Concentrations of macrophage-derived chemokine, eotaxin-2, monocyte chemotactic protein-1, growth-related oncogene, and interleukin-8 were similar between the 2 groups. When subjects were grouped according to disease severity, individuals with a plasma MIP-1alpha concentration >400 pM had a 10-times greater risk of having the more severe hepatosplenic form of disease. In the in vitro granuloma reaction, greater concentrations of MIP-1alpha were produced by cells of patients with hepatosplenic disease than cells of patients with intestinal disease. Pretreatment with a chemokine receptor antagonist attenuated the enhanced in vitro reaction seen with cells derived from patients with hepatosplenic disease. MIP-1alpha may not only mark a subset of patients with a greater risk of having more severe disease but also play a relevant pathophysiological role in human schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447751     DOI: 10.1086/345370

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  The role of MIP-1alpha in experimental hypersensitivity pneumonitis.

Authors:  M Schuyler; K Gott; V French
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Authors:  J B Guerreiro; S B Santos; D J Morgan; A F Porto; A L Muniz; J L Ho; A L Teixeira; M M Teixeira; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Schistosoma mansoni PCR+ -infected individuals in the Sudan present elevated systemic levels of chemokines when compared to uninfected and egg+ cohorts.

Authors:  K Arndts; T E M Elfaki; N Jelden; M Ritter; A Wiszniewsky; G Katawa; I A Goreish; M E Y A Atti El Mekki; M J Doenhoff; A Hoerauf; L E Layland
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

4.  Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation.

Authors:  Adriano L S Souza; Patrícia R S Souza; Cíntia A Pereira; Adriana Fernandes; Rodrigo Guabiraba; Remo C Russo; Leda Q Vieira; Ary Corrêa; Mauro M Teixeira; Deborah Negrão-Corrêa
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

5.  Role of Chemokines and Trafficking of Immune Cells in Parasitic Infections.

Authors:  Kathryn E McGovern; Emma H Wilson
Journal:  Curr Immunol Rev       Date:  2013

6.  Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis.

Authors:  Adriano L S Souza; Ester Roffê; Vanessa Pinho; Danielle G Souza; Adriana F Silva; Remo C Russo; Rodrigo Guabiraba; Cíntia A J Pereira; Flávia M Carvalho; Michele M Barsante; Rodrigo Correa-Oliveira; Lúcia A O Fraga; Deborah Negrão-Correa; Mauro M Teixeira
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Chemokines in onchocerciasis patients after a single dose of ivermectin.

Authors:  J Fendt; D M Hamm; M Banla; H Schulz-Key; H Wolf; G Helling-Giese; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 8.  Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Authors:  Maria-Jesus Pinazo; Maria-Carmen Thomas; Juan Bustamante; Igor Correia de Almeida; Manuel-Carlos Lopez; Joaquim Gascon
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

9.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

10.  Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection.

Authors:  Robson Da Paixão De Souza; Luciana Santos Cardoso; Giuseppe Tittoni Varela Lopes; Maria Cecília F Almeida; Ricardo Riccio Oliveira; Leda Maria Alcântara; Edgar M Carvalho; Maria Ilma Araujo
Journal:  J Parasitol Res       Date:  2012-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.